These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 22541418)
1. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Jamieson DJ; Chasela CS; Hudgens MG; King CC; Kourtis AP; Kayira D; Hosseinipour MC; Kamwendo DD; Ellington SR; Wiener JB; Fiscus SA; Tegha G; Mofolo IA; Sichali DS; Adair LS; Knight RJ; Martinson F; Kacheche Z; Soko A; Hoffman I; van der Horst C; Lancet; 2012 Jun; 379(9835):2449-2458. PubMed ID: 22541418 [TBL] [Abstract][Full Text] [Related]
2. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. ; de Vincenzi I Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718 [TBL] [Abstract][Full Text] [Related]
3. Antiretroviral interventions for preventing breast milk transmission of HIV. White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769 [TBL] [Abstract][Full Text] [Related]
4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N; van der Merwe L; Brocklehurst P; Sint TT Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394 [TBL] [Abstract][Full Text] [Related]
5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490 [TBL] [Abstract][Full Text] [Related]
6. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114 [TBL] [Abstract][Full Text] [Related]
7. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. Chasela CS; Hudgens MG; Jamieson DJ; Kayira D; Hosseinipour MC; Kourtis AP; Martinson F; Tegha G; Knight RJ; Ahmed YI; Kamwendo DD; Hoffman IF; Ellington SR; Kacheche Z; Soko A; Wiener JB; Fiscus SA; Kazembe P; Mofolo IA; Chigwenembe M; Sichali DS; van der Horst CM; N Engl J Med; 2010 Jun; 362(24):2271-81. PubMed ID: 20554982 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Coovadia HM; Brown ER; Fowler MG; Chipato T; Moodley D; Manji K; Musoke P; Stranix-Chibanda L; Chetty V; Fawzi W; Nakabiito C; Msweli L; Kisenge R; Guay L; Mwatha A; Lynn DJ; Eshleman SH; Richardson P; George K; Andrew P; Mofenson LM; Zwerski S; Maldonado Y; Lancet; 2012 Jan; 379(9812):221-8. PubMed ID: 22196945 [TBL] [Abstract][Full Text] [Related]
9. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Maréchal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tylleskär T; Van de Perre P; Lancet; 2016 Feb; 387(10018):566-573. PubMed ID: 26603917 [TBL] [Abstract][Full Text] [Related]
10. Delayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding. King CC; Kourtis AP; Persaud D; Nelson JA; Ziemniak C; Hudgens MG; Tegha G; Chasela CS; Jamieson DJ; van der Horst CM AIDS; 2015 Sep; 29(15):1953-61. PubMed ID: 26153671 [TBL] [Abstract][Full Text] [Related]
11. A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Kayira D; Bentley ME; Wiener J; Mkhomawanthu C; King CC; Chitsulo P; Chigwenembe M; Ellington S; Hosseinipour MC; Kourtis AP; Chasela C; Tembo M; Tohill B; Piwoz EG; Jamieson DJ; van der Horst C; Adair L; Am J Clin Nutr; 2012 Mar; 95(3):759-65. PubMed ID: 22258269 [TBL] [Abstract][Full Text] [Related]
12. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial. Thomas TK; Masaba R; Borkowf CB; Ndivo R; Zeh C; Misore A; Otieno J; Jamieson D; Thigpen MC; Bulterys M; Slutsker L; De Cock KM; Amornkul PN; Greenberg AE; Fowler MG; PLoS Med; 2011 Mar; 8(3):e1001015. PubMed ID: 21468300 [TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study. Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797 [TBL] [Abstract][Full Text] [Related]
14. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Guay LA; Musoke P; Fleming T; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Ducar C; Deseyve M; Emel L; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Dransfield K; Bray D; Mmiro F; Jackson JB Lancet; 1999 Sep; 354(9181):795-802. PubMed ID: 10485720 [TBL] [Abstract][Full Text] [Related]
15. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. Nagot N; Kankasa C; Meda N; Hofmeyr J; Nikodem C; Tumwine JK; Karamagi C; Sommerfelt H; Neveu D; Tylleskär T; Van de Perre P; BMC Infect Dis; 2012 Oct; 12():246. PubMed ID: 23039034 [TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
17. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Brocklehurst P; Volmink J Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666 [TBL] [Abstract][Full Text] [Related]
18. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Brocklehurst P; Volmink J Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis. Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304 [TBL] [Abstract][Full Text] [Related]
20. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. Kumwenda NI; Hoover DR; Mofenson LM; Thigpen MC; Kafulafula G; Li Q; Mipando L; Nkanaunena K; Mebrahtu T; Bulterys M; Fowler MG; Taha TE N Engl J Med; 2008 Jul; 359(2):119-29. PubMed ID: 18525035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]